000 01417 a2200421 4500
005 20250515051412.0
264 0 _c20070614
008 200706s 0 0 eng d
022 _a1043-3074
024 7 _a10.1002/hed.20527
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpeleman, Luciƫnne
245 0 0 _aPrognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.
_h[electronic resource]
260 _bHead & neck
_cApr 2007
300 _a341-50 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aCarcinoma, Squamous Cell
_xchemistry
650 0 4 _aCathepsin D
_xanalysis
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOropharyngeal Neoplasms
_xchemistry
650 0 4 _aPlasminogen Activator Inhibitor 1
_xanalysis
650 0 4 _aPrognosis
650 0 4 _aProto-Oncogene Proteins c-myc
_xanalysis
650 0 4 _aSurvival Rate
650 0 4 _aUrokinase-Type Plasminogen Activator
_xanalysis
700 1 _aKerrebijn, Jeroen D F
700 1 _aLook, Maxime P
700 1 _aMeeuwis, Cees A
700 1 _aFoekens, John A
700 1 _aBerns, Els M J J
773 0 _tHead & neck
_gvol. 29
_gno. 4
_gp. 341-50
856 4 0 _uhttps://doi.org/10.1002/hed.20527
_zAvailable from publisher's website
999 _c16732016
_d16732016